3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.

Celeste Porsbjerg,Anke H. Maitland van der Zee,Guy Brusselle,Giorgio Walter Canonica,Alvar Agusti,Rosa Faner,Claus Vogelmeier,Martijn C. Nawijn,Maarten van den Berge,Franca Rusconi,Charles Pilette,Valeria Ramiconi,Courtney Coleman,Rekha Chaudhuri,Kian Fan Chung,Jadwiga A. Wedzicha,Sejla Saglani,Marc P. van der Schee,Liam G. Heaney,Arnaud Bourdin,Graham Roberts,Ratko Djukanovic,Piotr Kuna,Maciej Kupczyk,Judith Axmann,Heribert Staudinger,Graham W. Clarke,Sven-Erik Dahlén,Christopher E. Brightling

3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.

2021

3TR, the largest IMI consortium ever in immune diseases, brings clinical researchers and scientists from several disease areas together, in an endeavour to increase the clinical impact of targeted immune-mediated therapies, including asthma and COPDhttps://bit.ly/3kPq0xI

Keywords:

Medicine
Disease
COPD
pan european
Intensive care medicine
Asthma
Immune Diseases

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations